AM

Amplitude Surgical SAPAR Amplitude Stock Report

Last reporting period 31 Dec, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.179

Micro

Exchange

XPAR - Euronext Paris

AMPLI.PA Stock Analysis

AM

Uncovered

Amplitude Surgical SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

45/100

Low score

Market cap $B

0.179

Dividend yield

Shares outstanding

48.021 B

Amplitude Surgical SAS engages in the manufacturing, marketing and design of orthopedic products. The company is headquartered in Valence, Auvergne-Rhone-Alpes and currently employs 460 full-time employees. The company went IPO on 2015-06-26. The firm offers the AMPLIVISION system, a computer navigation workstation and its related software, which is fully developed by the Company in collaboration with surgeons. Each implant is validated mechanically by creating models and running tests on simulators. Amplitude Surgical SAS relies on the expertise of its design offices and on scientific partnerships to internally design and develop its implants and automatic or computer-navigated instruments. The company operates through ofab Orthopedie, a strategic industrial subcontractor

View Section: Eyestock Rating